Details of the Drug
General Information of Drug (ID: DMLXKZH)
| Drug Name |
EUPAFOLIN
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
6-Methoxyluteolin; 520-11-6; Nepetin; EUPAFOLIN; 2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-6-methoxy-4H-chromen-4-one; Eurafolin; UNII-I3O7LF3GED; I3O7LF3GED; CHEMBL172350; NSC122416; 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6-methoxy-; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6-methoxychromen-4-one; SMR000440634; Pedaltin; NSC 122416; AC1NSVCV; MLS000728561; MLS000877025; SCHEMBL828390; MEGxp0_000458; cid_5317284; ACon1_000516; BDBM23412; DTXSID10199959; FHHSEFRSDKWJKJ-UHFFFAOYSA-N; REGID_for_CID_5317284
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 316.26 | |||||||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | 1.4 | ||||||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 2 | ||||||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 4 | ||||||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 7 | ||||||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||


